Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.
BACKGROUND: It is well known that the global population is aging and that those over the age of 80 are the fastest growing part of this expansion. Also known is that prevalence of hypertension and cognitive decline both increase with increasing age. METHOD: The Hypertension in the Very Elderly Trial...
Main Authors: | Peters, R, Beckett, N, Forette, F, Tuomilehto, J, Ritchie, C, Walton, I, Waldman, A, Clarke, R, Poulter, R, Fletcher, A, Bulpitt, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
by: Peters, R, et al.
Published: (2008) -
Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)
by: Thijs Lutgarde, et al.
Published: (2006-12-01) -
Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.
by: Ruth Peters, et al.
Published: (2010-07-01) -
Treatment of White Coat HYpertension in the Very Elderly Trial (HYVET 2) - Feasibility of a Randomized Controlled Trial (Study Protocol)
by: Michael Okorie, et al.
Published: (2019-11-01) -
HYVET Study results: importance for clinical practice
by: S. V. Nedogoda
Published: (2008-10-01)